[Latest Edition] Active Pharmaceutical Ingredients Market Worth 347.22 Billion to 2031 | Reveals InsightAce Study
May 01, 2023 09:21 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, May 01, 2023 (GLOBE NEWSWIRE) -- The Global Active Pharmaceutical Ingredients Market is estimated to reach over USD 347.22 billion by 2031, exhibiting a CAGR of 6.7% during the...
Active Pharmaceutical Ingredients Market Size & Share to Surpass $308.96 Billion by 2028 | Vantage Market Research
April 09, 2023 21:18 ET
|
Vantage Market Research
WASHINGTON, April 09, 2023 (GLOBE NEWSWIRE) -- Global Active Pharmaceutical Ingredients Market is valued at USD 189.51 Billion in 2021 and is projected to reach a value of USD 308.96 Billion by 2028...
Active Pharmaceutical Ingredient Market to Cross USD 347.92 Billion by 2030 owing to Increasing Outsourcing of API Manufacturing | Report by SNS Insider
March 14, 2023 10:45 ET
|
SNS Insider pvt ltd
Pune, March 14, 2023 (GLOBE NEWSWIRE) -- SNS Insider predicts that the Active Pharmaceutical Ingredient Market will attain a value of USD 347.92 billion by 2030, having been valued at USD 211.81...
High Potency Active Pharmaceutical Ingredients Market to Reach a Revenue of Around US$ 23.3 Billion by the End of 2023 at a CAGR of 11.1%, States Persistence Market Research
February 02, 2023 09:30 ET
|
Persistence Market Research
New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The High-potency pharmaceutical active ingredients market revenues were estimated at US$ 21.2 Billion in 2022 and is anticipated to grow at a CAGR of...
Global Active Pharmaceutical Ingredients Market Size to Reach $360 billion by 2030, Growing at a CAGR of 6.2% Report by Beyond Market Insights (Industry Share, Growth, Analysis and Forecast from 2023 to 2030)
January 11, 2023 10:28 ET
|
Beyond Market Insights
Atlanta, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Active Pharmaceutical Ingredients Market Overview: API's are the element of drugs that are beneficial for health effects. It delivers biologically active...
Benuvia, a Leading Drug Developer Focused on Pharmaceutical Cannabinoids, with the FDA Approved Drug SYNDROS®, Signs Definitive Agreement to Become a Publicly Traded Company through a Business Combination with Pono Capital Corp
March 18, 2022 06:00 ET
|
Pono Capital Corp.
Benuvia, a leading drug developer focused on pharmaceutical cannabinoids has entered into a definitive business combination agreement with Pono Capital Corp (Nasdaq: PONOU)The transaction implies a...
Global Active Pharmaceutical Ingredients Market Poised To Expand
June 26, 2018 04:00 ET
|
BCC Research
WELLESLEY, Mass., June 26, 2018 (GLOBE NEWSWIRE) -- Over the next five years, the global market for active pharmaceutical ingredients (APIs) will be driven by increased demand for pharmaceutical...
Active Pharmaceutical Ingredients Market to Expand at Impressive 6.3% CAGR till 2023; Market Sees Rising Preference for Contract Manufacturing and Biologics: TMR
May 13, 2016 07:30 ET
|
Transparency Market Research
Albany, NY, May 13, 2016 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research “Active Pharmaceutical Ingredient Market: Global Industry Analysis, Size,...
Genomatica Expands Bioengineering Solutions Business
April 12, 2016 09:00 ET
|
Genomatica
SAN DIEGO, April 12, 2016 (GLOBE NEWSWIRE) -- Genomatica announced they are expanding their Bioengineering Solutions business across the chemical, health (e.g. active pharmaceutical ingredients,...